Breakingviews - A $40 bln deal for Tylenol trusts the M&A science - Reuters
Breakingviews - A $40 bln deal for Tylenol trusts the M&A science Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQaU91eHRsZ0cyWkRTVUtiWThHaV9kSEN4OEF0Y1VnOU1DY1dQaE8tUWlDbl9wcXJsek1rSUlRWVBOTTJrcWV0MjRFLVlwbnJ6bG1DOHNKLXBiZ2hHODVocnU5X0VTamdsNm1zSkxnVFdSWFRQT0Z0cnhIbGlnTUJuOGdjYWY5alZsM1JZYUNzWVN1ZnQ0OVdmbnNncEEwV0k?oc=5" target="_blank">Breakingviews - A $40 bln deal for Tylenol trusts the M&A science</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal - Reuters
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal Reuters
August 28, 2026 at 08:12 AMWalmart settles US government's opioid lawsuit, which sought billions, for $50 million - Reuters
Walmart settles US government's opioid lawsuit, which sought billions, for $50 million Reuters
August 28, 2026 at 10:29 PMExxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reports - Reuters
Exxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reports Reuters
August 24, 2026 at 04:12 AMMarvell selloff deepens as investors seek clarity on Google AI deal payoff - Reuters
Marvell selloff deepens as investors seek clarity on Google AI deal payoff Reuters
August 28, 2026 at 02:15 PMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMMarvell raises annual forecasts, but shares fall as Google deal questions linger - Reuters
Marvell raises annual forecasts, but shares fall as Google deal questions linger Reuters
August 27, 2026 at 11:10 PM